임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
40건 표시
- 1상모집 중· Healthy Male VolunteersA Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults
리드: 화이자
- 1상모집 중· Advanced MalignanciesAn Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
리드: 화이자
- 1상모집 중· Renal ImpairmentA Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
리드: 화이자
- 1상모집 중· Advanced Breast CancerA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
리드: 화이자
- 1상모집 중· Healthy ParticipantsA Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
리드: 화이자
- 1상모집 중· Non-muscle Invasive Bladder CancerA Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
리드: 화이자
- 1상모집 중· Advanced/Metastatic Solid TumorsA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
리드: 화이자
- 1상모집 중· Healthy ParticipantsA Study to Learn About a Vaccine Against E Coli in Healthy Adults
리드: 화이자
- 1상모집 중· Acute Treatment of MigraineA Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
리드: 화이자
- 1상모집 중· Severe Hemophilia AA Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
리드: 화이자
- 1상모집 중· Androgen Deprivation TherapyRelugolix + Enzalutamide Study in High-Risk Prostate Cancer
협력: 화이자
- 1상모집 중· Healthy ParticipantsFIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
리드: 화이자
- 1상모집 중· Colorectal NeoplasmsA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
리드: 화이자 · 협력: 사노피
- 1상모집 중· Carcinoma, Non-Small-Cell LungA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
리드: 화이자
- 1상모집 중· Metastatic Breast CancerPhase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
협력: 노바티스, 화이자
- 1상모집 중· Advanced Malignant Solid NeoplasmTrifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
협력: 화이자
- 1상모집 중· Triple Negative Breast CancerPAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
협력: 화이자
- 1상모집 중· Myelodysplastic SyndromeA Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
리드: 화이자
- 1상모집 중· Metastatic Castration Resistant Prostate Cancer (mCRPC)A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
리드: 화이자
- 1상모집 중· Tumor, SolidUlixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.